Premium Essay

Unimed and Edumed

In: Business and Management

Submitted By bombastiku
Words 857
Pages 4
Case study UniMed and EduMed 1. What are the key markets factors that drove UniMed’s business model?
UNIMED Medical Supplies is an expert supplier of therapeutic supplies and extras item. The organization built up following 2002 by Dr. Zachary and his child Oscar. Plan of action of UniMed's make the business sector engaging quality by enter United States and Europe. UniMed's main goal is was to drastically enhance restorative administrations for patients living in the Middle East by making Western pharmaceutical promptly available. UniMed's business idea was to join telemedicine capacities with a world class system of restorative organizations and doctors to make a productive medicinal administration. By giving access to a broad system of restorative establishments through telemedicine innovation and UniMed's tried to offer second assessments, e-counseling and patient referral administration administrations for the patient who can travel abroad for medicinal analysis and treatment. The UniMed's additionally had accessible assets and generally low preparing costs. The business sector figures likewise make the Unimed get to be solid and the building associations with the other.

2. What were some of the core elements in creating the UniMed business?
The center component in making UniMed’s business is enhancing restorative administrations for patients by making western promptly available. Satellite office likewise the center components of UniMed's which is make a referral administration. Patients ready to go outside the Middle East to get second conclusions or surgery start their procedure with an examination of their alternatives at the UniMed's office. The staff additionally gives all alternative that fall inside patient’s parameters so they can settle on the best choice. UniMed's was situating itself as a creative administration that it was trusted would…...

Similar Documents

Premium Essay

Why Marijuana Illegal

...going through chemotherapy develop. After Marinol’s production it was found that the drug was also useful in treating AIDS wasting. AIDS wasting is occurs when a person infected with AIDS looses more than 10% of their body weight. (Mostly muscle) Alstimer patients are benefiting from its use as well Marinol has been found beneficial in treating appetite loss and behavioral disturbances associated with the disease. “Another likely market for Marinol consists of people with AIDS who receive combination antiretroviral therapy. For these patients Dronabinol offers a double benefit: not only does the drug stimulate appetite, it also appears to relieve nausea and vomiting, common side effects of the standard daily doses of antiretroviral drugs. Unimed is presently conducting a Phase II study in this area; if the results are promising, the company plans to seek FDA approval for the additional indication” (Aldrich & Mathre,1997). The FDA is also considering medical marijuana or Dexanabinol in the treatment for Neuroprotection stroke, multiple sclerosis, Parkinson’s, and Alzheimer’s. The investor Pharmos Corporation has seen positive response in phase II of the drug and has begun phase III. The THC plant is in the second phase of III in England for treating spinal cord injury, Multiple Sclerosis and, pain. After reading the facts you cannot help but agree that marijuana should be used for medicinal purposes. Whether you agree that marijuana has multiple benefits for cancer and......

Words: 1227 - Pages: 5

Premium Essay

Problems & Prospects of Pharmaceuticals in Bangladesh

...organization and they remit their profit to their parent country, they are paying different types of tariffs and taxes to the government of Bangladesh. Importing: Importing is acquiring or purchasing the goods or products which have been made in another country (Skinner & Iv ancevich, 2003). Bangladesh is importing the medicinal products from different countries, especially from India. Different organizations of this country are related to import the pharmaceuticals products and raw materials of pharmaceutical industries. Novo and Medintis are importing maximum amount of these types of products. Other organizations are engaging to import the pharmaceuticals products. They are- Sanofi, Aventis, Glaxo Smithkline, Sandoz, Novartis, Roche, Unimed, Servier etc. [pic] This chart explains that the consumption of medicine and imported amount of medicine is increasing year by year. In 2007, Bangladesh imported huge amount of medicine due to some political and social problems. The imported amount of 2008 is lower than the previous year. According to drug administration, the production was high in 2008. For this reason the imported amount was low and political unrest is the reason for increasing the imported amount and declining the exported amount in 2007. [pic] [pic] From the above figure, it can be easily found that the maximum demand of medicine is met by the product produced by our locally established organization (locally owned and multinational). The production and imported......

Words: 2796 - Pages: 12

Premium Essay

Corporate Competitive Strategy

...2 7.0 26.0 19.8 36.1 30.0 13.6 14.4 26.1 12.4 26.6 42.2 13.4 6.6 14.5 22.7 23.7 35.0 42.4 32.1 21.0 25.4 Medco Containment Svces, Inc. Newport Pharm. Int’l, Inc. Noble Roman’s Inc. No. American Holding Corp. No. Hills Electronics, Inc. Photographic Sciences Corp Presidential Life Corp Pride Petroleum Svces, Inc. Quadrex Corp. Quality Care, Inc. Ragen Precision Industries, Inc. REN Corp-USA REN Corp-USA Rentrak Corp. Ryan’s Family Steak Houses, Inc. Ryan’s Family Steak Houses, Inc. Sahlen & Assoc., Inc. Starrett Housing Corp. Sudbury Holdings, Inc. Superior Care, Inc. Sym-Tek Systems, Inc. Telepictures Corp. Velo-Bind, Inc. Western Digital Corp. 50-Off Stores, Inc. ARC Capital Dense Pac Microsystems, Inc. Nobel Education Dynamics, Inc. Unimed Pharmaceuticals Mean 15.5% 37.8% 17.2% 30.4% 36.6% 49.5% 15.9% 24.5% 39.4% 34.4% 15.3% 17.9% 29.3% 32.5% 8.7% 5.2% 27.5% 44.8% 46.5% 41.9% 31.6% 11.6% 19.5% 47.3% 12.5% 18.8% 23.1% 19.3% 15.8% 27.1% 4 6 7 8 9 10 11 13 14 15 16 17 19 20 21 22 23 24 25 26 27 Regression #1 Regression Statistics Multiple R R square Adjusted R square Standard error Observations ANOVA df Regression Residual Total 7 45 52 Coefficients Intercept Rev2 Shares sold-$ Mkt cap Earn stab Rev stab AvgYrs2Sell Price stab 0.0673 4.629E-18 3.619E-09 4.789E-10 0.1038 0.1824 0.1722 0.0037 SS 0.6354 0.3432 0.9786 Standard Error 0.1082 9.913E-19 1.199E-09 1.790E-10 0.0402 0.0531 0.0362 8.316E-04 MS 0.0908 0.0076 t Stat 0.6221 4.6698 3.0169 2.6754 2.5831 3.4315......

Words: 214584 - Pages: 859

Premium Essay


... Page 11 * IBN Sina * Jayson Pharmaceuticals Ltd. * Incepta Pharmaceuticals * MonicoPharma Ltd. Bangladesh * Novo Healthcare & Pharma Limited * Opsonin Pharma Limited * Orion Pharma Limited * Paradise Chemical Industries * Popular Pharmaceuticals Limited * Renata Limited * Syntho Laboratories Limited * Silva Pharmaceutical Limited * Supreme Pharmaceuticals Limited * Sonear Laboratories Limited * UniMed & UniHealth Pharma Limited * Zenith Pharmaceuticals Ltd. Page 12 SWOT ANALYSIS:   A SWOT analysis identifies and assesses the strengths, weaknesses, opportunities and threats an organization faces. SWOT analysis of the SPL illustrates to upper management what the company is excelling in, what improvements need to be made, where growth is possible and what preemptive measures need to be taken to protect shareholder or company value. Strengths: The strength of Square Pharmaceuticals Ltd. lies in its diversified products and dosage forms. SPL has been......

Words: 3192 - Pages: 13

Free Essay

CaracteríSticas Gerais Do Sistema Nacional de InovaçãO

...esposa Viviane, aos meus sobrinhos Gabriel e Rafael, e minha irmã Andréia pelos incentivos e carinho. A toda minha família que sempre esteve presente na minha vida. Agradeço a minha querida sobrinha Vanessa, que me ajudou nas traduções dos textos. A minha grande amiga, minha irmã de coração, Mary Angela, que leu este trabalho várias vezes, me ajudando na correção e revisão. Nunca esquecerei do seu apoio, seu carinho e seus incentivos. Aos meus amigos e amigas: Edivânia, Wagner, Fran, Leonardo e Charles, que sempre estiveram junto a mim na faculdade. Muitas risadas, choro, companheirismo, festas e muita amizade; nunca esquecerei vocês. A uma pessoa especial, Márcio, pelas palavras de carinho e conforto. Aos meus grandes amigos da UNIMED pelo carinho e apoio. Ao meu orientador prof. Renato e ao Pablo pela ajuda, sugestões, críticas e dedicação. A todos os professores que me orientaram durante o curso. vii RESUMO PAIVA, Amanda Rosa de. Características Gerais do Sistema Nacional de Inovação Brasileiro: uma comparação com Rússia, Índia e China (BRIC’s). 2008, 77 páginas. Ciências Econômicas. Universidade Federal de Santa Catarina, Florianópolis. O presente estudo procura apresentar, uma revisão de literatura sobre os conceitos de Sistema Nacional de Inovação, destacando a inovação, conhecimento e aprendizado pela visão neoschumpeteriana. Os conceitos abordados são importantes para o entendimento do desenvolvimento dos sistemas de inovação dos países......

Words: 21373 - Pages: 86

Free Essay

Abc Ltd.

...visit the event website: www. We are eagerly looking forward to seeing you at the Asia Pharma Expo 2011. Thanking you Yours sincerely Managing Director Incepta Pharmaceuticals Ltd. JOINT CONVER Dr. Momenul Haq Managing Director General Pharmaceuticals Ltd. MEMBERS Mr. Kh. Tarique-ul-lslam Managing Director Medimet Pharmaceuticals Ltd. Managing Director Globe Pharmaceuticals Ltd. Managing Director Renata Ltd. Mr. Md. Harunur Rashid Mr. Syed S Kaiser Kabir Mr. Iftekharul Islam Managing Director Sanofi-Aventis Bangladesh Ltd. Mr. A M Faruque Managing Director Eskayef Bangladesh Ltd. Dr. Mostafizur Rahman Managing Director Popular Pharmaceuticals Ltd. Mr. M Mosaddek Hossain Managing Director UniMed & UniHealth Manufacturers Ltd. Mr. Mohammad Yusuf Managing Director Drug International Ltd. Mr. M M Rahman Khan Dr. Md. Zakir Hossain Managing Director Peoples Pharma Ltd. Managing Director Delta Pharma Ltd. Mr. Feroz Uddin Khan Managing Director Edruc Ltd. Mr. Md. Halimuzzaman Salman F Rahman Executive Director Healthcare Pharmaceuticals Ltd. SOUTH ASIA ONE OF THE RAPIDLY GROWING PHARMA REGION § § § § § ADVISOR Mr. Nazmul Hassan, MP One of the fastest growing pharma economy of the world The rapid growth rate to meet the Demand & Supply statistics of India, Bangladesh, Nepal, Pakistan, Bhutan, Myanmar, Thailand, and Indonesia has attracted the global attention Over-all growth rate of the South Asian......

Words: 3538 - Pages: 15

Premium Essay

Valuation of Ambee Pharmaceuticals Limited, Bangladesh

...only a few local companies (usually the leading ones) that are engaged in manufacturing APIs. So, most of the bargaining power is concentrated amongst the foreign firms from which the companies import ingredients. Suppliers also have a lot of power over buyers as the suppliers’ product or service is critical to buyers’ business. 7 A M B E E P H A R M A : V A L U A T I O N Different organizations of this country are related to import the pharmaceuticals products and raw materials of pharmaceutical industries. Novo and Medintis are importing maximum amount of these types of products. Other organizations are engaging to import the pharmaceuticals products. They are- Sanofi, Aventis, Glaxo-Smithkline, Sandoz, Novartis, Roche, Unimed, Servier etc. In order to have Active Pharmaceutical Ingredients (API) in a country, one has to pass through as many as 16 stages. But Bangladesh does not have such a number of facilities because it is thickly populated country. Besides, to Doha Declaration on WTO-TRIPS and Public Health: have the competitive edge in such an industry and to be self reliant in all the stages of production, it will require huge investment. In such a process, the industries will eventually eat up the competitive edge. A possible remedy, could be that the industries in Bangladesh could bring in intermediaries from the third or fourth or fifth stages and then the companies could began API production in the country. Some of the intermediaries of raw material......

Words: 5420 - Pages: 22